We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXps Pensions Regulatory News (XPS)

Share Price Information for Xps Pensions (XPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 255.00
Bid: 255.00
Ask: 258.00
Change: 1.00 (0.39%)
Spread: 3.00 (1.176%)
Open: 250.00
High: 258.00
Low: 241.00
Prev. Close: 254.00
XPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of the Open Offer

3 Jan 2018 07:00

RNS Number : 7813A
Xafinity PLC
03 January 2018
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT, WHICH DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT, IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, AND NEITHER THIS ANNOUNCEMENT NOR ANYTHING HEREIN FORMS THE BASIS FOR ANY CONTRACT OR COMMITMENT WHATSOEVER.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

3 January 2018

Xafinity plc

Results of the Open Offer

 

On 7 December 2017, Xafinity plc ("Xafinity" or the "Company") (ticker: XAF), the pensions actuarial, consulting and administration business, announced details of a Capital Raising to raise gross proceeds of approximately £70 million through the issue of 30,645,990 Firm Placing Shares and 10,530,480 Open Offer Shares, in each case at an issue price of 170 pence per Capital Raising Share. The Open Offer Shares were conditionally placed with institutional investors at the Offer Price, subject to clawback to satisfy valid applications by Qualifying Shareholders pursuant to the Open Offer. The Firm Placing Shares were not subject to clawback and were not part of the Open Offer. The Open Offer closed for acceptances at 11.00 a.m. on 2 January 2018.

The Company announces that it has received applications in respect of 18,540,627 Open Offer Shares from Qualifying Shareholders under the Open Offer and Excess Application Facility, representing a proportion of approximately 176.06 per cent of the Open Offer Shares offered. In total, 9,907,771 Open Offer Shares are to be allotted and issued in satisfaction of Open Offer Entitlements under the Open Offer (representing all of the valid acceptances received in relation to Open Offer Entitlements) and 622,709 Open Offer Shares are to be allotted and issued pursuant to the Excess Application Facility.

The Firm Placing and Placing and Open Offer are conditional upon, among other things, the approval of the Resolutions by Shareholders at the Company's General Meeting to be held at 10.30 a.m. on 4 January 2018. It is expected that Admission of the Capital Raising Shares will occur and that dealings in the Capital Raising Shares will commence at 8:00 a.m. on 5 January 2018.

Capitalised terms used but not defined in this announcement have the same meaning as set out in the prospectus dated 7 December 2017 that was published by Xafinity on 8 December 2017.

The persons responsible for arranging for the release of this announcement on behalf of the Company are the Directors.

 

For further information:

 

Xafinity plc

Paul Cuff, Co-CEO

+44 (0) 118 918 5110

Deloitte LLP (Sponsor and Financial Adviser)

+44 (0) 20 7936 3000

Byron Griffin

Chris Nicholls

Peter Stewart

 

Zeus Capital Limited (Joint Bookrunner and Sole Broker)

+44 (0) 20 3829 5000

Martin Green

Pippa Underwood

John Goold

 

Liberum Capital Limited (Joint Bookrunner and Sole Underwriter)

Richard Crawley

Robert Morton

Cameron Duncan

+44 (0) 20 3100 2000

Camarco

Ed Gascoigne-Pees

Nick Hennis

+44 (0) 20 3757 4980

 

Important Notices

 

This announcement is an advertisement and does not constitute a prospectus or prospectus equivalent document. Nothing in this announcement should be interpreted as a term or condition of the Capital Raising. Investors should not subscribe for or purchase any New Ordinary Shares except on the basis of the information contained in the Prospectus or otherwise incorporated by reference into the Prospectus.

This announcement does not constitute or form part of any offer or invitation to purchase, or otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security in the capital of the Company in any jurisdiction.

The information contained in this announcement is not for release, publication or distribution to persons in the United States, Australia, Canada, Japan or the Republic of South Africa or in any jurisdiction where to do so would breach any applicable law. The New Ordinary Shares have not been and will not be registered under the securities laws of such jurisdictions and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an exemption from and in compliance with any applicable securities laws. No public offer of the New Ordinary Shares is being made by virtue of this announcement in or into the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction outside the United Kingdom in which such offer would be unlawful. No action has been or will be taken by the Company, the Directors, Deloitte, Zeus Capital or Liberum, or any other person, to permit a public offering or distribution of this announcement or any other offering or publicity materials for the New Ordinary Shares in any jurisdiction where action for that purpose may be required, other than in the United Kingdom.

THIS ANNOUNCEMENT DOES NOT CONTAIN OR CONSTITUTE AN OFFER FOR THE SOLICITATION OF AN OFFER TO PURCHASE SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT, OR WITH ANY SECURITIES REGULATORY AUTHORITY OF ANY STATE OF THE UNITED STATES OR OTHER JURISDICTION AND MAY NOT BE OFFERED, SOLD, RESOLD, TRANSFERRED OR DELIVERED WITHIN THE UNITED STATES EXCEPT PURSUANT TO AN EXEMPTION FROM OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND IN COMPLIANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION OF THE UNITED STATES. THERE WILL BE NO PUBLIC OFFER OF SECURITIES IN THE UNITED STATES.

This announcement has been issued by, and is the sole responsibility of, the Company.

Deloitte Corporate Finance, a division of Deloitte LLP ("Deloitte"), has been appointed as sponsor and financial adviser to the Company. Deloitte is authorised and regulated in the United Kingdom by the FCA in respect of regulated activities and is acting exclusively for the Company and no one else in connection with the transactions and arrangements described in this announcement. Deloitte will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the transactions and arrangements described in this announcement and will not be responsible for providing the protections afforded to Deloitte's clients nor for giving advice in relation to the contents of this announcement or the transactions and arrangements described in this announcement. Deloitte is not responsible for the contents of this announcement.

Zeus Capital Limited ("Zeus Capital") has been appointed as joint bookrunner and sole broker to the Company. Zeus Capital is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company and no one else in connection with the transactions and arrangements described in this announcement. Zeus Capital will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the transactions and arrangements described in this announcement and will not be responsible for providing the protections afforded to Zeus Capital's clients, nor for giving advice in relation to the contents of this announcement or the transactions and arrangements described in this announcement. Zeus Capital is not responsible for the contents of this announcement.

Liberum Capital Limited ("Liberum") has been appointed as joint bookrunner and sole underwriter to the Company. Liberum is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for the Company and no one else in connection with the transactions and arrangements described in this announcement. Liberum will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the transactions and arrangements described in this announcement and will not be responsible for providing the protections afforded to Liberum's clients, nor for giving advice in relation to the contents of this announcement or the transactions and arrangements described in this announcement. Liberum is not responsible for the contents of this announcement.

This announcement has been prepared for the purposes of complying with the applicable laws and regulations of the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRMMGGMMZRGRZZ
Date   Source Headline
11th Apr 20247:00 amRNSPost-close trading update
10th Apr 202411:18 amRNSStandard form for notification of major holdings
8th Apr 20249:04 amRNSTR-1: Standard form for notification of holdings
20th Mar 202410:41 amRNSStandard form for notification of major holdings
19th Mar 20241:32 pmRNSHolding(s) in Company
7th Mar 20243:54 pmRNSResults of General Meeting held on 7 March 2024
6th Mar 20242:10 pmRNSHolding(s) in Company
6th Mar 202410:15 amRNSHolding(s) in Company
23rd Feb 20247:22 amRNSListing Rule 9.6.14(2) Disclosure
22nd Feb 202410:22 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading update and Notice of General Meeting
7th Feb 202411:14 amRNSDirector/PDMR Shareholding
18th Jan 20243:12 pmRNSBlock Listing Six Monthly Return
13th Dec 20234:49 pmRNSDirector/PDMR Shareholding
13th Dec 20233:13 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSNon-Executive Director Appointments
5th Dec 202310:28 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSInvestor Presentation
23rd Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSXPS completes the sale of NPT to SEI
13th Nov 20239:00 amRNSXPS appointed to provide services to John Lewis
23rd Oct 20233:58 pmRNSHolding(s) in Company
19th Oct 202312:12 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSPost-close trading update
13th Oct 202312:50 pmRNSNotice of Trading Update
9th Oct 20236:22 pmRNSHolding(s) in Company Replacement
9th Oct 20234:53 pmRNSHolding(s) in Company
7th Sep 20233:30 pmRNSResults of Annual General Meeting
5th Sep 20239:54 amRNSAGM Update
1st Sep 20232:13 pmRNSHolding(s) in Company
1st Sep 20232:10 pmRNSTotal Voting Rights and Share Capital
25th Aug 20233:33 pmRNSDirector/PDMR Shareholding
26th Jul 20234:01 pmRNSDirector/PDMR Shareholding
26th Jul 20237:10 amRNSChairman directorship notification
21st Jul 202311:30 amRNSInvestor Presentation
20th Jul 202310:53 amRNSDirector/PDMR Shareholding
18th Jul 20239:30 amRNSBlock listing Interim Review
17th Jul 20237:00 amRNSDirector/PDMR Shareholding
14th Jul 20234:45 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSNPT Strategic Partnership with SEI
13th Jul 20239:23 amRNSAnnual Report & Accounts 2022/23 and Notice of AGM
4th Jul 202311:20 amRNSDirector/PDMR Shareholding
26th Jun 202312:29 pmRNSHolding(s) in Company
23rd Jun 20234:01 pmRNSStatement re: press speculation
22nd Jun 20237:00 amRNSFinal Results
13th Jun 20235:01 pmRNSHolding(s) in Company
1st Jun 20233:27 pmRNSHolding(s) in Company
24th May 20237:00 amRNSCapital Markets Event & Post-close trading update
22nd Mar 20237:00 amRNSPre-close trading update
21st Feb 20237:00 amRNSNon-Executive Director Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.